Respiratory syncytial virus (RSV) usually causes mild, cold-like symptoms in most people, but it is the leading cause of infant hospitalization in the U.S.

Aug 30, 2024 · RSV is a common respiratory virus that usually causes mild, cold-like symptoms. Infants and older adults are more likely to develop severe RSV and need hospitalization. CDC recommends immunizations to protect infants, some young children, and older adults.

Aug 30, 2024 · RSV usually causes mild, cold-like symptoms. Most RSV infections go away on their own. RSV can be serious for babies, some young children, and older adults. There is no treatment for RSV, but you can manage symptoms with over-the-counter medications.

Aug 30, 2024 · Respiratory syncytial virus (RSV) causes respiratory illness among persons of all age groups. RSV is one of the most common causes of childhood illness and is the most common cause of hospitalization in infants.

Sep 4, 2024 · Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious. Infants and older adults are more likely to develop severe RSV and need hospitalization. Vaccines are available to protect older adults from severe RSV.

Aug 30, 2024 · RSV can spread when an infected person coughs or sneezes, by direct contact with someone who has RSV, or by touching a contaminated surface. In most regions of the United States, RSV season generally starts during the fall and peaks in the winter.

Aug 30, 2024 · RSV can be dangerous for older adults, especially those who have certain medical conditions, are elderly or frail, or live in a nursing home. CDC recommends everyone ages 75 and older get an RSV vaccine.

Aug 30, 2024 · RSV can be dangerous for infants and some young children. RSV is the leading cause of infant hospitalization in the U.S. Immunizations can protect babies from getting very sick from RSV.

Oct 17, 2024 · CDC recommends a one-time-dose of RSV vaccine for everyone 75 years and older and for adults 60 through 74 years of age who are at increased risk of severe RSV disease. Adults 60 through 74 years old who are at increased risk include those with chronic heart or lung disease, a weakened immune system, or certain other chronic medical conditions ...

CDC recommends a respiratory syncytial virus (RSV) vaccine for pregnant women to protect their babies from severe RSV disease. Pregnant women should get a single dose of the maternal RSV vaccine (Pfizer’s Abrysvo) during weeks 32 through 36 of pregnancy.